Patient Info

Lecicarbon Prescribing information (please consult the SmPC before prescribing)

Lecicarbon A contains sodium dihydrogen carbonate (0.5g per suppository) and sodium dihydrogen phosphate (0.680g per suppository). Indications: Lecicarbon A is used in all forms of frequent constipation (habitual or chronic), especially where the rectal emptying reflex is weak; constipation due to low-fibre food or insufficient exercise (bedridden patients); to evacuate the bowel prior to surgery or diagnostic procedures (e.g. x-rays, rectoscopy and before childbirth); can be used in addition to other laxatives if they have been proven to be ineffective. Contraindications: Lecicarbon A should not be used in cases of ileus (intestinal obstruction), in case of all anal and rectal region diseases that can lead to an excessive absorption of carbon dioxide, especially in children and infants, and in the case of hypersensitivity against soya, peanut or to one of the excipients of Lecicarbon A suppository. In the presence of toxic megacolon, the product should only be used with explicit permission of the treating physician. Side effects: Rarely Soya lecithin has been known to cause allergic reactions. The insertion of the suppository can very occasionally cause a slight burning sensation, which quickly disappears. Dosage and method of use: Insert one suppository into the rectum, if needed this can be repeated after 30-60 minutes. MA number: PL 28418/0001. Cost: £8.20 MAH: Athenstaedt GmbH & Co KG, Am Beerberg 1, 35088 Battenberg, Germany. Distributed by: Aspire Pharma Ltd, Bellamy House, Winton Road, Petersfield, Hampshire, GU32 3HA. Legal category: P. Date last reviewed: August 2014.


For further information, please call: 01730 231148, email: info@aspirepharma.co.uk
or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Lecicarbon A, please see full prescribing information.
Revision date ?? March 2015